At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4007 Pharmacy
Closed 02-04 16:00:00 EST
917.29
+33.37
+3.77%
High921.18Low883.71Vol429.83M
Open883.92D1 Closing883.93Amplitude4.24%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O24.29BT/O Rate--Tradable Shares0.00
P/B5.468424ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

India's Lupin Launches Seizure Drug Bioequivalent to Supernus Pharmaceuticals' Trokendi XR
MT Newswires Live  ·  03:45
India's Lupin Launches Seizure Drug Bioequivalent to Supernus Pharmaceuticals' Trokendi XR
BUZZ-Veradermics soars in NYSE debut after upsized $256.3 million IPO
Reuters  ·  03:12
BUZZ-Veradermics soars in NYSE debut after upsized $256.3 million IPO
Dozens of Stocks Hitting 52-Week Highs -- WSJ
Dow Jones  ·  02:45
Dozens of Stocks Hitting 52-Week Highs -- WSJ
What's Going On With Bristol-Myers Squibb Stock Today?
Benzinga_recent_news  ·  02:40
What's Going On With Bristol-Myers Squibb Stock Today?
Prestige Consumer management to meet with Oppenheimer
TIPRANKS  ·  02:35
Prestige Consumer management to meet with Oppenheimer
BGM Group Down Over 30%, on Track for Record Low Close and Record Percent Decrease -- Data Talk
Dow Jones  ·  02:15
BGM Group Down Over 30%, on Track for Record Low Close and Record Percent Decrease -- Data Talk
Roche price target raised to CHF 295 from CHF 290 at Morgan Stanley
TIPRANKS  ·  01:55
Roche price target raised to CHF 295 from CHF 290 at Morgan Stanley
Dogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
TIPRANKS  ·  01:35
Dogwood Therapeutics: Strengthened Capital Structure, Advancing Pain Pipeline, and Extended IP Support a Buy-Rated Risk-Reward Profile
Nasdaq Dips Over 400 Points; Eli Lilly Shares Surge Following Upbeat Earnings
Benzinga_recent_news  ·  01:32
Nasdaq Dips Over 400 Points; Eli Lilly Shares Surge Following Upbeat Earnings
Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead
Benzinga  ·  01:25
Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead
Novo Nordisk Says FDA Approves Ozempic Pill, Set to be Available in US in Q2
MT Newswires Live  ·  01:14
Novo Nordisk Says FDA Approves Ozempic Pill, Set to be Available in US in Q2
TDG Gold Extends Aurora West Mineralization and Uncovers New Porphyry Target in B.C.
TIPRANKS  ·  01:07
TDG Gold Extends Aurora West Mineralization and Uncovers New Porphyry Target in B.C.
Hikma Pharmaceuticals Rallies Wednesday, Outperforms Market
Dow Jones  ·  01:05
Hikma Pharmaceuticals Rallies Wednesday, Outperforms Market
Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market
Dow Jones  ·  01:02
Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market
BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST
Reuters  ·  01:00
BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST
GSK Up Nearly 7%, On Pace for Highest Close Since April 2014 -- Data Talk
Dow Jones  ·  00:39
GSK Up Nearly 7%, On Pace for Highest Close Since April 2014 -- Data Talk
Top Midday Stories: Lilly Shares Soar After Strong Q4 Earnings, Guidance; Uber Q4 EPS Misses Target, CFO Stepping Down
MT Newswires Live  ·  00:36
Top Midday Stories: Lilly Shares Soar After Strong Q4 Earnings, Guidance; Uber Q4 EPS Misses Target, CFO Stepping Down
Pfizer and BioNTech Pause modRNA Shingles Ambitions
TIPRANKS  ·  00:31
Pfizer and BioNTech Pause modRNA Shingles Ambitions
Pfizer Price Target Maintained With a $27.00/Share by Cantor Fitzgerald
Dow Jones  ·  00:29
Pfizer Price Target Maintained With a $27.00/Share by Cantor Fitzgerald
Eli Lilly Reclaims $1 Trillion Market Cap After ‘Blowout Earnings’
TIPRANKS  ·  00:12
Eli Lilly Reclaims $1 Trillion Market Cap After ‘Blowout Earnings’

Introduction

Company Name.
BK4007
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--